Evidence map›Paper›PMID 30390176›Full record

ArticleJournal of assisted reproduction and genetics2019

Evaluation of Z-VAD-FMK as an anti-apoptotic drug to prevent granulosa cell apoptosis and follicular death after human ovarian tissue transplantation.

Maïté Fransolet, Laure Noël, Laurie Henry, Soraya Labied, Silvia Blacher, Michelle Nisolle, Carine Munaut

Open access · greenAbstract read
In one paragraph

Article in Journal of assisted reproduction and genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maïté FransoletLaboratory of Tumor and Developmental Biology, GIGA-R, University of Liège, Tour de Pathologie (B23), Avenue Hippocrate, 13, Sart Tilman, B-4000, Liège, Belgium.
Laure NoëlLaboratory of Tumor and Developmental Biology, GIGA-R, University of Liège, Tour de Pathologie (B23), Avenue Hippocrate, 13, Sart Tilman, B-4000, Liège, Belgium.
Laurie HenryDepartment of Gynecology and Obstetrics, CPMA, University of Liège, CHR de la Citadelle, Boulevard du 12ième de Ligne, 1, B-4000, Liège, Belgium.
Soraya LabiedDepartment of Gynecology and Obstetrics, CPMA, University of Liège, CHR de la Citadelle, Boulevard du 12ième de Ligne, 1, B-4000, Liège, Belgium.
Silvia BlacherLaboratory of Tumor and Developmental Biology, GIGA-R, University of Liège, Tour de Pathologie (B23), Avenue Hippocrate, 13, Sart Tilman, B-4000, Liège, Belgium.
Michelle NisolleLaboratory of Tumor and Developmental Biology, GIGA-R, University of Liège, Tour de Pathologie (B23), Avenue Hippocrate, 13, Sart Tilman, B-4000, Liège, Belgium.
Carine MunautLaboratory of Tumor and Developmental Biology, GIGA-R, University of Liège, Tour de Pathologie (B23), Avenue Hippocrate, 13, Sart Tilman, B-4000, Liège, Belgium. c.munaut@ulg.ac.be.ORCID http://orcid.org/0000-0003-4952-9637
University of Liège · BE

Funding

Direction Générale Opérationnelle Agriculture, Ressources Naturelles et Environnement du Service Public de Wallonie -Fonds De La Recherche Scientifique - FNRS -Fonds De La Recherche Scientifique - FNRS 7.4597.12 - 7.4622.14 - 7.4590.16Fonds Léon Fredericq -
6 · The paper itself

Abstract

purposeTo evaluate the efficiency of ovarian tissue treatment with Z-VAD-FMK, a broad-spectrum caspase inhibitor, to prevent follicle loss induced by ischemia/reperfusion injury after transplantation.

methodsIn vitro, granulosa cells were exposed to hypoxic conditions, reproducing early ischemia after ovarian tissue transplantation, and treated with Z-VAD-FMK (50 μM). In vivo, cryopreserved human ovarian fragments (n = 39) were embedded in a collagen matrix containing or not Z-VAD-FMK (50 μM) and xenotransplanted on SCID mice ovaries for 3 days or 3 weeks.

resultsIn vitro, Z-VAD-FMK maintained the metabolic activity of granulosa cells, reduced HGL5 cell death, and decreased PARP cleavage. In vivo, no improvement of follicular pool and global tissue preservation was observed with Z-VAD-FMK in ovarian tissue recovered 3-days post-grafting. Conversely, after 3 weeks of transplantation, the primary follicular density was higher in fragments treated with Z-VAD-FMK. This improvement was associated with a decreased percentage of apoptosis in the tissue.

conclusionsIn situ administration of Z-VAD-FMK slightly improves primary follicular preservation and reduces global apoptosis after 3 weeks of transplantation. Data presented herein will help to guide further researches towards a combined approach targeting multiple cell death pathways, angiogenesis stimulation, and follicular recruitment inhibition.

Indexed as

Amino Acid Chloromethyl KetonesAnimalsApoptosisCaspase InhibitorsFemaleGranulosa CellsHumansMice, SCIDOvarian FollicleReperfusion InjuryTransplantation, HeterologousAmino Acid Chloromethyl Ketonesbenzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneCaspase InhibitorsApoptosisFertility preservationGranulosa cellsOvarian tissue transplantationZ-VAD-FMK

Identifiers

PMID30390176
PMCPMC6420548
OpenAlexW2410304408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.